Zika Virus

Zika virus is a member of the virus family Flaviviridae and the genus Flavivirus, transmitted by daytime-active Aedes mosquitoes, such as A. aegypti and A. albopictus
What is the Zika virus?

The Zika virus causes fever, joint pain, headaches, a rash, conjunctivitis and muscle pain. As with other viruses, it is characterised by spreading via the cells of the body. Both men and women can contract the disease. It is a member of the Flavivirus genus which is a member of the Flaviviridae family.

Read More

Overview

Feature Articles

Latest Zika Virus News and Research

New study disproves suspicion that dengue raises risk of zika-related microcephaly

New study disproves suspicion that dengue raises risk of zika-related microcephaly

Plant compounds inhibit Mpro of SARS-CoV-2 and HCoV-229E in vitro

Plant compounds inhibit Mpro of SARS-CoV-2 and HCoV-229E in vitro

The technology behind face masks that can diagnose COVID-19

The technology behind face masks that can diagnose COVID-19

Differences in monocyte subsets between severe COVID-19 and long COVID

Differences in monocyte subsets between severe COVID-19 and long COVID

COVID-19 virus can infect the testes, hamster study shows

COVID-19 virus can infect the testes, hamster study shows

The role of natural killer cells in fight against viral infections including SARS-CoV-2

The role of natural killer cells in fight against viral infections including SARS-CoV-2

Equitable sharing of bioimaging technologies is crucial for global health

Equitable sharing of bioimaging technologies is crucial for global health

Anti-viral treatment can stop the spread of lab modeled SARS-CoV-2 by 99.5%

Anti-viral treatment can stop the spread of lab modeled SARS-CoV-2 by 99.5%

Anti-viral treatment can stop the spread of lab modeled SARS-CoV-2 by 99.5%

Anti-viral treatment can stop the spread of lab modeled SARS-CoV-2 by 99.5%

SNPRC at Texas Biomed awarded $37 million NIH grant to continue operations into 2026

SNPRC at Texas Biomed awarded $37 million NIH grant to continue operations into 2026

Role of traditional medicine against SARS-CoV-2

Role of traditional medicine against SARS-CoV-2

The great promise of antiviral peptides against SARS-CoV-2

The great promise of antiviral peptides against SARS-CoV-2

Researchers develop rapid antibody screening method for novel COVID-19 therapeutics development

Researchers develop rapid antibody screening method for novel COVID-19 therapeutics development

Researchers detect Zika virus RNA in free-ranging African bats

Researchers detect Zika virus RNA in free-ranging African bats

UVA researchers shed new light on brain development

UVA researchers shed new light on brain development

Study sheds new light on human brain development

Study sheds new light on human brain development

New DNA COVID-19 vaccine proven effective in mice

New DNA COVID-19 vaccine proven effective in mice

Could 6′,6′-difluoro-aristeromycin (DFA) have broad-spectrum antiviral potential against coronaviruses?

Could 6′,6′-difluoro-aristeromycin (DFA) have broad-spectrum antiviral potential against coronaviruses?

Novel broad-spectrum antiviral compounds effective against Zika and SARS-CoV-2

Novel broad-spectrum antiviral compounds effective against Zika and SARS-CoV-2

Phosphatidic acid is a key common substrate for hepatitis C and SARS-CoV-2 replication

Phosphatidic acid is a key common substrate for hepatitis C and SARS-CoV-2 replication